Merck: ACIP recommends Capvaxive for people over 65
This recommendation also includes guidelines for adults aged 19 to 64 under certain medical conditions.
Capvaxive is designed to prevent invasive disease and pneumonia caused by several strains of Streptococcus pneumoniae.
Copyright (c) 2024 CercleFinance.com. All rights reserved.
Go to the original article.
Contact us to request a correction